Global Glucagon Like Peptide 2 Receptor Market By Product Type (FE-203799, Glepaglutide) And By End-Users/Application (Short Bowel Syndrome, Diabetes) Global Market Share, Forecast Data, In-Depth Analysis, And Detailed Overview, and Forecast, 2013 - 2026

  • AMR-984716
  • April 2021
  • Pharmaceuticals
  • 110 Pages

Report Preview

The global Glucagon Like Peptide 2 Receptor market research report provides complete study and detail analysis of the market. This study includes forecast analysis of the market which is based on global and regional level, whereas the research reports the provides forecast data from 2020-2028 and historic of 2018 and 2019. All the values are based on revenue USD Million. Moreover, the market research report describes various segments of the Glucagon Like Peptide 2 Receptor market based on its types, applications and end-use industry. The applications of the market are explained in different industry verticals with reference to major countries across the globe. Along with this, the research report also covers all the major players that are operating in the global Glucagon Like Peptide 2 Receptor market. These major players of the market are further studied and analyzed based on various parameters, such as annual market revenue, annual sales of the company, marketing strategy, historic growth and shipment volumes. Based on all the company’s insights, the market research analyst also suggests business strategy and marketing plans for improving the market position of existing participants of Glucagon Like Peptide 2 Receptor market.

Apart from this, the market research report also covers drivers and restraints for the global Glucagon Like Peptide 2 Receptor market and their impact on the demand and supply during the forecast period. Along with this, the research report also provides Glucagon Like Peptide 2 Receptor market trends and opportunities that are based on regional and global level. Furthermore, the market research report also provides the major distributors and manufacturers that are operating in all the key region across the world. The researched data provided in the report is widely used by various industry players to strengthen their distribution channel and improve the geographical reach. In addition, the report also covers all the major players of the global Glucagon Like Peptide 2 Receptor market and its key offerings and solutions. The report also provides recent mergers and acquisitions of these key players.

XYZ Market Strategic Analysis:
In 2019, the global XYZ market was valued at US$ xx Mn, and it is expected to reach at US$ xx Mn at a CAGR of xx% during 2020-2028.

The data which is provided in the market research report is analyzed and evaluated with the help of various marketing tools, such as SWOT analysis, Poster’s Five Force analysis, PESTEL analysis, value chain analysis, player positioning analysis and market share analysis. Therefore, this analysis tools helps the analyst to evaluate the Glucagon Like Peptide 2 Receptor market based on various parameters such as capital investments, impact of consumer’s preferences, economies of scale, manufacturing rights and patents, existing distribution channels, switching costs, government regulations and brand loyalty. 
 
Report Parameters Details of Parameter
Market Size xx Million
Based Year 2019
Forecast Period Covered 2019 – 2028
Units for value Revenue in USD million and CAGR from 2020 to 2028
Covered Segments Component, Types, Applications, End-Users, and more.
Product Type FE-203799, Glepaglutide, GXG-8, HM-15910, Others
Applications Short Bowel Syndrome, Diabetes, Diarrhea, Obesity, Others
Region Covered North America, Europe, Asia Pacific, Latin America, Middle East and Africa
Companies Covered Hanmi Pharmaceuticals Co Ltd, Naia Ltd, Takeda, Tasly Pharmaceutical Group Co Ltd, Zealand Pharma AS

Glucagon Like Peptide 2 Receptor Market Segment Analysis:
The Glucagon Like Peptide 2 Receptor market research report segments the market based on its types, applications and end-use industry. All the segments of the market are analyzed and evaluated based on current and future trends of the market. The data for the segments and its categories is provided from 2018 to 2028. 

Glucagon Like Peptide 2 Receptor Market, by Type: FE-203799, Glepaglutide, GXG-8, HM-15910, Others

Glucagon Like Peptide 2 Receptor Market, by Application: Short Bowel Syndrome, Diabetes, Diarrhea, Obesity, Others

Major Key Players for Global Glucagon Like Peptide 2 Receptor Market:
The Glucagon Like Peptide 2 Receptor market research report offers the company profile of major key players including progress trends, competitive landscape breakdown, and key in regions development status. Hanmi Pharmaceuticals Co Ltd, Naia Ltd, Takeda, Tasly Pharmaceutical Group Co Ltd, Zealand Pharma AS

Geographic Coverage for Glucagon Like Peptide 2 Receptor Market:
The market research report on global Glucagon Like Peptide 2 Receptor market offers complete analysis across various regions across the world. The Glucagon Like Peptide 2 Receptor market is distributed into various regions such as North America, Europe, Asia Pacific, Latin America and Middle East and Africa. The global leading market share as per the region is evaluated after considering Glucagon Like Peptide 2 Receptor market revenue, sales, shares, recent developments, innovations and growth rates. This section of regional analysis provides widespread evaluation of the industry from various countries and regions.

North America Glucagon Like Peptide 2 Receptor Market Value and Forecast
  • US
  • Canada

Europe Glucagon Like Peptide 2 Receptor Market Value and Forecast
  • UK
  • Germany
  • France
  •  Rest of Europe

Asia Pacific Glucagon Like Peptide 2 Receptor Market Value and Forecast
  • China
  • Japan
  • India
  • Rest of Asia Pacific

Latin America Glucagon Like Peptide 2 Receptor Market Value and Forecast
  • Mexico
  • Brazil
  • Rest of Latin America

Middle East and Africa Glucagon Like Peptide 2 Receptor Market Value and Forecast
  • GCC Countries
  • South Africa
  • Rest of Middle East and Africa



Key highlights of the Glucagon Like Peptide 2 Receptor market report:
  • The report provides key trends of the global Glucagon Like Peptide 2 Receptor market
  • The report also covers consumer preferences and current industry growth
  • Key products or solutions offered by the main players in the Glucagon Like Peptide 2 Receptor industry
  • The report covers all the recent developments of the Glucagon Like Peptide 2 Receptor market and helps to provide current industry updates
  • The report covers a detailed look over the global Glucagon Like Peptide 2 Receptor Industry and provides with significant actionable insights
  • The Glucagon Like Peptide 2 Receptor market estimation from 2020-2028 and historical data for 2018 and 2019
  • The market study also provides data on changing market dynamics, market intelligence, current and future market trends
  • The report also analyses the microeconomic and macroeconomic factors that are affecting the global Glucagon Like Peptide 2 Receptor market
  • In-depth analysis of the market’s competitive landscape and detailed information about the vendors
  • The report also offers key market drivers, restrains, trends and opportunities with present and future impact on the market
  • Detailed information about the major players or manufacturers of the global Glucagon Like Peptide 2 Receptor market
  • Comprehensive analysis of the Glucagon Like Peptide 2 Receptor market segments based on its types, applications and end-use industry

Key Analytical Areas:
The report aims to offer a complete solution to various businesses operating in the Glucagon Like Peptide 2 Receptor market in making strategic decisions based on credible information and actionable insights. Thereby, the report covers various aspects of your requirements such as industry overview, market dynamics, regional analysis and competitive landscape. The report aims to provide insights to businesses in the Glucagon Like Peptide 2 Receptor market for numerous purposes such as:

     1. Strategic Decision Making:
With the help of this report, key decision makers can quickly analyze and identify growth opportunities in terms of numerous segments across various geographical regions. Thereby, this report enables organizations to identify and make strategic investments in specific market segments in order to gain maximum return on investment.

      2.  Actionable Insights:
The report offers a deep dive into how companies are leveraging market conditions to make the most in the Glucagon Like Peptide 2 Receptor market. Thereby, the report offers numerous actionable insights into the best practices and key success factors relevant in the Glucagon Like Peptide 2 Receptor market. Using the insights included in the report, businesses can make quick decisions to achieve success in business operations.

      3. Competitive Snapshot:
In addition, to detailed information on the companies operating in the Glucagon Like Peptide 2 Receptor market, the report also includes a competitive snapshot of all the companies covered in the report. Thereby, this offers a visual representation of how all the companies stand comparatively based on their competencies, geographic presence, market hold, years of operations, employee and financial strength, among others.

Have query on this report?

Make an Enquiry
1. Preface
     1.1. Report Scope and Description
     1.2. Research Methodology
          1.2.1. Phase I-Secondary Research
          1.2.2. Phase II-Primary Research
          1.2.3. Phase II-Expert Panel Review
          1.2.4. Assumptions
          1.2.5. Approach Adopted

2. Executive Summary
     2.1. Global Glucagon Like Peptide 2 Receptor Market Snapshot
          2.1.1. Global Glucagon Like Peptide 2 Receptor Market By Type,2019
               2.1.1.1.FE-203799
               2.1.1.2.Glepaglutide
               2.1.1.3.GXG-8
               2.1.1.4.HM-15910
               2.1.1.5.Others
          2.1.2. Global Glucagon Like Peptide 2 Receptor Market By Application,2019
               2.1.2.1.Short Bowel Syndrome
               2.1.2.2.Diabetes
               2.1.2.3.Diarrhea
               2.1.2.4.Obesity
               2.1.2.5.Others
          2.1.3. Global Glucagon Like Peptide 2 Receptor Market By End-use,2019
          2.1.4. Global Glucagon Like Peptide 2 Receptor Market By Geography,2019

3. Global Glucagon Like Peptide 2 Receptor Market Dynamics
     3.1. Market Overview
     3.2. Market Inclination Insights Analysis
     3.3. Drivers
     3.4. Challenges
     3.5. Future Prospects
     3.6. Impact Analysis of Drivers and Challenges During the Forecast Period, (2020-2028)

4. Global Glucagon Like Peptide 2 Receptor Market Size (US$), By Type, 2018 – 2028 
     4.1. Overview
          4.1.1. Market Share Analysis By Type, 2019 vs.2028
          4.1.2. Attractive Investment Proposition By Type, 2020
     4.2. Global Glucagon Like Peptide 2 Receptor Market Size (US$), By Type, 2018 – 2028

5. Global Glucagon Like Peptide 2 Receptor Market Size (US$), By Application, 2018 – 2028 
     5.1. Overview
          5.1.1. Market Share Analysis By Application, 2019 vs.2028
          5.1.2. Attractive Investment Proposition By Application, 2020
     5.2. Global Glucagon Like Peptide 2 Receptor Market Size (US$), By Application, 2018 – 2028

6. Global Glucagon Like Peptide 2 Receptor Market Size (US$), By End-use, 2018 – 2028 
     6.1. Overview
          6.1.1. Market Share Analysis By End-use, 2019 vs.2028
          6.1.2. Attractive Investment Proposition By End-use, 2020
     6.2. Global Glucagon Like Peptide 2 Receptor Market Size (US$), By End-use, 2018 – 2028

7. Global Glucagon Like Peptide 2 Receptor Market Size (US$), By Geography, 2018 – 2028
     7.1. Overview
          7.1.1. Market Share Analysis by Geography, 2019 vs. 2028
          7.1.2. Attractive Investment Proposition by Geography, 2020
     7.2. North America Glucagon Like Peptide 2 Receptor Market Analysis, 2018 – 2028 
          7.2.1. North America Glucagon Like Peptide 2 Receptor Market Size (US$), By Country, 2018 – 2028 
               7.2.1.1. U.S.
               7.2.1.2. Canada
          7.2.2. North America Glucagon Like Peptide 2 Receptor Market Size (US$), By Type, 2018 – 2028
          7.2.3. North America Glucagon Like Peptide 2 Receptor Market Size (US$), By Application, 2018 – 2028
          7.2.4. North America Glucagon Like Peptide 2 Receptor Market Size (US$), By End-use, 2018 – 2028
     7.3. Europe Glucagon Like Peptide 2 Receptor Market Analysis, 2018 – 2028 
          7.3.1.  Europe Glucagon Like Peptide 2 Receptor Market Size (US$), By Country, 2018 – 2028 
               7.3.1.1. U.K.
               7.3.1.2. Germany
               7.3.1.3. France
               7.3.1.4. Rest of Europe
          7.3.2. Europe Glucagon Like Peptide 2 Receptor Market Size (US$), By Type, 2018 – 2028
          7.3.3. Europe Glucagon Like Peptide 2 Receptor Market Size (US$), By Application, 2018 – 2028
          7.3.4. Europe Glucagon Like Peptide 2 Receptor Market Size (US$), By End-use, 2018 – 2028
     7.4. Asia Pacific Glucagon Like Peptide 2 Receptor Market Analysis , 2018 – 2028
          7.4.1.  Asia Pacific Glucagon Like Peptide 2 Receptor Market Size (US$), By Country, 2018 – 2028 
               7.4.1.1. China
               7.4.1.2. Japan
               7.4.1.3. India
               7.4.1.4. Rest of Asia Pacific
          7.4.2. Asia Pacific Glucagon Like Peptide 2 Receptor Market Size (US$), By Type, 2018 – 2028
          7.4.3. Asia Pacific Glucagon Like Peptide 2 Receptor Market Size (US$), By Application, 2018 – 2028
          7.4.4. Asia Pacific Glucagon Like Peptide 2 Receptor Market Size (US$), By End-use, 2018 – 2028
     7.5. Latin America Glucagon Like Peptide 2 Receptor Market Analysis, 2018 – 2028 
          7.5.1.  Latin America Glucagon Like Peptide 2 Receptor Market Size (US$), By Country, 2018 – 2028 
               7.5.1.1. Brazil
               7.5.1.2. Mexico
               7.5.1.3. Rest of Latin America
          7.5.2. Latin America Glucagon Like Peptide 2 Receptor Market Size (US$), By Type, 2018 – 2028
          7.5.3. Latin America Glucagon Like Peptide 2 Receptor Market Size (US$), By Application, 2018 – 2028
          7.5.4. Latin America Glucagon Like Peptide 2 Receptor Market Size (US$), By End-use, 2018 – 2028
     7.6. Middle East & Africa (MEA) Glucagon Like Peptide 2 Receptor Market Analysis, 2018 – 2028 
          7.6.1.  MEA Glucagon Like Peptide 2 Receptor Market Size (US$), By Region, 2018 – 2028 
               7.6.1.1. GCC Countries
               7.6.1.2. South Africa
               7.6.1.3. Rest of MEA
          7.6.2. MEA Glucagon Like Peptide 2 Receptor Market Size (US$), By Type, 2018 – 2028
          7.6.3. MEA Glucagon Like Peptide 2 Receptor Market Size (US$), By Application, 2018 – 2028
          7.6.4. MEA Glucagon Like Peptide 2 Receptor Market Size (US$), By End-use, 2018 – 2028

8. Company Profiles
     8.1. Competitive Analysis 
     8.2. Market Positioning of Key Vendors 
     8.3. Key Strategies adopted by the Leading Players
     8.4. Key Glucagon Like Peptide 2 Receptor Providers
        8.4.1 Hanmi Pharmaceuticals Co Ltd
                8.1.1 Business Description
                8.1.2 Hanmi Pharmaceuticals Co Ltd Geographic Operations
                8.1.3 Hanmi Pharmaceuticals Co Ltd Financial Information
                8.1.4 Hanmi Pharmaceuticals Co Ltd Product Positions/Portfolio
                8.1.5 Hanmi Pharmaceuticals Co Ltd Key Developments
        8.4.2 Naia Ltd
                8.2.1 Business Description
                8.2.2 Naia Ltd Geographic Operations
                8.2.3 Naia Ltd Financial Information
                8.2.4 Naia Ltd Product Positions/Portfolio
                8.2.5 Naia Ltd Key Developments
        8.4.3 Takeda
                8.3.1 Business Description
                8.3.2 Takeda Geographic Operations
                8.3.3 Takeda Financial Information
                8.3.4 Takeda Product Positions/Portfolio
                8.3.5 Takeda Key Developments
        8.4.4 Tasly Pharmaceutical Group Co Ltd
                8.4.1 Business Description
                8.4.2 Tasly Pharmaceutical Group Co Ltd Geographic Operations
                8.4.3 Tasly Pharmaceutical Group Co Ltd Financial Information
                8.4.4 Tasly Pharmaceutical Group Co Ltd Product Positions/Portfolio
                8.4.5 Tasly Pharmaceutical Group Co Ltd Key Developments
        8.4.5 Zealand Pharma AS
                8.5.1 Business Description
                8.5.2 Zealand Pharma AS Geographic Operations
                8.5.3 Zealand Pharma AS Financial Information
                8.5.4 Zealand Pharma AS Product Positions/Portfolio
                8.5.5 Zealand Pharma AS Key Developments

LIST OF TABLES

TABLE 1 Market Snapshot: Global Glucagon Like Peptide 2 Receptor Market 
TABLE 2 Impact Indicators 
TABLE 3 Impact Analysis of Drivers and Restraints 
TABLE 4 North America Glucagon Like Peptide 2 Receptor Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 5 North America Glucagon Like Peptide 2 Receptor Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 6 North America Glucagon Like Peptide 2 Receptor Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 7 Europe Glucagon Like Peptide 2 Receptor Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 8 Europe Glucagon Like Peptide 2 Receptor Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 9 Europe Glucagon Like Peptide 2 Receptor Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 10 Asia Pacific Glucagon Like Peptide 2 Receptor Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 11 Asia Pacific Glucagon Like Peptide 2 Receptor Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 12 Asia Pacific Glucagon Like Peptide 2 Receptor Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 13 Latin America Glucagon Like Peptide 2 Receptor Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 14 Latin America Glucagon Like Peptide 2 Receptor Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 15 Latin America Glucagon Like Peptide 2 Receptor Market Revenue, By End-use, 2018 – 2028 (US$ Mn)
TABLE 16 MEA Glucagon Like Peptide 2 Receptor Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 17 MEA Glucagon Like Peptide 2 Receptor Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 18 MEA Glucagon Like Peptide 2 Receptor Market Revenue, By End-use, 2018 – 2028 (US$ Mn)

LIST OF FIGURES

FIG. 1 Global Glucagon Like Peptide 2 Receptor: Market Segmentation 
FIG. 2 Global Glucagon Like Peptide 2 Receptor Market: Research Methodology 
FIG. 3 Top-Down and Bottom-up Approach 
FIG. 4 Global Glucagon Like Peptide 2 Receptor Market, By Type, 2019 (US$ Mn) 
FIG. 5 Global Glucagon Like Peptide 2 Receptor Market, By Application, 2019 (US$ Mn) 
FIG. 6 Global Glucagon Like Peptide 2 Receptor Market, By End-use, 2019 (US$ Mn) 
FIG. 7 Global Glucagon Like Peptide 2 Receptor Market, By Geography, 2019 (US$ Mn) 
FIG. 8 Global Glucagon Like Peptide 2 Receptor Market Revenue and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG. 9 Attractive Investment Proposition 
FIG. 10 Market Positioning of Key Glucagon Like Peptide 2 Receptor Providers, 2019
FIG. 11 Global Glucagon Like Peptide 2 Receptor Market Revenue Contribution, By Type, 2019 & 2028 (Value %) 
FIG. 12 Global Glucagon Like Peptide 2 Receptor Market Revenue Contribution, By Application, 2019 & 2028 (Value %) 
FIG. 13 Global Glucagon Like Peptide 2 Receptor Market Revenue Contribution, By End-use, 2019 & 2028 (Value %) 
FIG. 14 North America Glucagon Like Peptide 2 Receptor Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 15 Europe Glucagon Like Peptide 2 Receptor Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 16 Asia Pacific Glucagon Like Peptide 2 Receptor Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 17 Latin America Glucagon Like Peptide 2 Receptor Market Revenue, 2018 – 2028, (US$ Mn)
FIG. 18 MEA Glucagon Like Peptide 2 Receptor Market Revenue, 2018 – 2028, (US$ Mn)

Key Takeaways:

1. Market value and estimate of the Glucagon Like Peptide 2 Receptor market for the period from 2020 to 2028
2. Compounded annual growth rate (CAGR%) for individual segments in various regional markets for a period from 2020 to 2028
3. Value chain analysis
4. Market share study combined with competitive landscape of major players
5. Profiles of major market players covering overall business operations, geographic occurrence, product portfolio, financial status and news coverage 

List of Tables

TABLE  Market Snapshot: Global Glucagon Like Peptide 2 Receptor Market
TABLE  Impact Pointers
TABLE  Impact Analysis of Drivers and Restraints
TABLE  North America Glucagon Like Peptide 2 Receptor Market Value, By Segment1, 2018 – 2028
TABLE  North America Glucagon Like Peptide 2 Receptor Market Value, By Segment2, 2018 – 2028
TABLE  North America Glucagon Like Peptide 2 Receptor Market Value, By Country, 2018 – 2028
TABLE  Europe Glucagon Like Peptide 2 Receptor Market Value, By Segment1, 2018 – 2028
TABLE  Europe Glucagon Like Peptide 2 Receptor Market Value, By Segment2, 2018 – 2028
TABLE  Europe Glucagon Like Peptide 2 Receptor Market Value, By Country, 2018 – 2028
TABLE  Asia Pacific Glucagon Like Peptide 2 Receptor Market Value, By Segment1, 2018 – 2028
TABLE  Asia Pacific Glucagon Like Peptide 2 Receptor Market Value, By Segment2, 2018 – 2028
TABLE  Asia Pacific Glucagon Like Peptide 2 Receptor Market Value, By Country, 2018 – 2028
TABLE  Latin America Glucagon Like Peptide 2 Receptor Market Value, By Segment1, 2018 – 2028
TABLE  Latin America Glucagon Like Peptide 2 Receptor Market Value, By Segment2, 2018 – 2028
TABLE  Latin America Glucagon Like Peptide 2 Receptor Market Value, By Country, 2018 – 2028
TABLE  MEA Glucagon Like Peptide 2 Receptor Market Value, By Segment1, 2018 – 2028
TABLE  MEA Glucagon Like Peptide 2 Receptor Market Value, By Segment2, 2018 – 2028
TABLE  MEA Glucagon Like Peptide 2 Receptor Market Value, By Country, 2018 – 2028
TABLE  Hanmi Pharmaceuticals Co Ltd: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Naia Ltd: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Takeda: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Tasly Pharmaceutical Group Co Ltd: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Zealand Pharma AS: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
 

List of Figures

FIG.  Global Glucagon Like Peptide 2 Receptor Market: Research Methodology
FIG.  Top-Down and Bottom Up Approach
FIG.  Global Glucagon Like Peptide 2 Receptor Market, By Segment1, 2019 (US$ Mn)
FIG.  Global Glucagon Like Peptide 2 Receptor Market, By Segment2, 2019 (US$ Mn)
FIG.  Global Glucagon Like Peptide 2 Receptor Market, By Geography, 2019 (US$ Mn)
FIG.  Global Glucagon Like Peptide 2 Receptor Market Value and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG.  Attractive Investment Proposition
FIG.  Market Positioning of Key Glucagon Like Peptide 2 Receptor Providers, 2016
FIG.  Global Glucagon Like Peptide 2 Receptor Market Value Share, By Segment1, 2019 & 2028 (% Value)
FIG.  Global FE-203799 Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Glepaglutide Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global GXG-8 Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global HM-15910 Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Others Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Glucagon Like Peptide 2 Receptor Market Value Share, By Segment2, 2019 & 2028 (% Value)
FIG.  Global Short Bowel Syndrome Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Diabetes Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Diarrhea Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Obesity Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Others Market Value, 2018 – 2028, (US$ Mn)
FIG.  U.S. Glucagon Like Peptide 2 Receptor Market Value, 2018 – 2028, (US$ Mn)
FIG.  Canada Glucagon Like Peptide 2 Receptor Market Value, 2018 – 2028, (US$ Mn)
FIG.  UK Glucagon Like Peptide 2 Receptor Market Value, 2018 – 2028, (US$ Mn)
FIG.  Germany Glucagon Like Peptide 2 Receptor Market Value, 2018 – 2028, (US$ Mn)
FIG.  France Glucagon Like Peptide 2 Receptor Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Europe Glucagon Like Peptide 2 Receptor Market Value, 2018 – 2028, (US$ Mn)
FIG.  China Glucagon Like Peptide 2 Receptor Market Value, 2018 – 2028, (US$ Mn)
FIG.  Japan Glucagon Like Peptide 2 Receptor Market Value, 2018 – 2028, (US$ Mn)
FIG.  India Glucagon Like Peptide 2 Receptor Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Asia Pacific Glucagon Like Peptide 2 Receptor Market Value, 2018 – 2028, (US$ Mn)
FIG.  Mexico Glucagon Like Peptide 2 Receptor Market Value, 2018 – 2028, (US$ Mn)
FIG.  Brazil Glucagon Like Peptide 2 Receptor Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Latin America Glucagon Like Peptide 2 Receptor Market Value, 2018 – 2028, (US$ Mn)
FIG.  GCC Countries Glucagon Like Peptide 2 Receptor Market Value, 2018 – 2028, (US$ Mn)
FIG.  South Africa Glucagon Like Peptide 2 Receptor Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of MEA Glucagon Like Peptide 2 Receptor Market Value, 2018 – 2028, (US$ Mn)